Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
Interferon-alpha (IFNα) has been used to treat chronic hepatitis C virus (HCV) infection for over 20 years with varying efficacy, depending on the infecting viral genotype. The mechanism of action of IFNα is not fully understood, but is thought to target multiple stages of the HCV lifecycle, inhibit...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2014
|
| Online Access: | https://eprints.nottingham.ac.uk/47401/ |